The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

Molecular Pharmacology

Volumn 63, Issue 4, 2003, Pages 908-914

  Bensaid, M ^a   Gary Bobo, M ^a   Esclangon, A ^a   Maffrand, J P ^a   Le Fur, G ^a   Oury donat, F ^a   Soubrie P ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 2 RECEPTOR; MESSENGER RNA; PLASMA PROTEIN; PROTEIN ACRP30; RIMONABANT; UNCLASSIFIED DRUG; ADIPONECTIN; CANNABINOID; CANNABINOID RECEPTOR; DRUG RECEPTOR; PIPERIDINE DERIVATIVE; PROTEIN; PYRAZOLE DERIVATIVE; SIGNAL PEPTIDE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID OXIDATION; FOOD INTAKE; GENE OVEREXPRESSION; HORMONAL REGULATION; HYPERGLYCEMIA; HYPERINSULINEMIA; MALE; METABOLIC REGULATION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; RAT STRAIN; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; HYPERINSULINISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; ZUCKER RAT;

3T3 CELLS; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CANNABINOIDS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HYPERINSULINISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; OBESITY; PIPERIDINES; PROTEIN BIOSYNTHESIS; PROTEINS; PYRAZOLES; RATS; RATS, ZUCKER; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER;

EID: 0037374766     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.4.908     Document Type: Article

References (33)

1. Allison DB, Fontaine KR, Manson JE, Stevens J, and VanItallie TB (1999) Annual deaths attributable to obesity in the United States. J Am Med Assoc 282:1530-1538.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83.
3. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, and Le Fur G (1997) Selective inhibition ofsucrose and ethanol intake by SR 141716, an antagonist of central carmabinoid (CB1) receptors. Psychopharmacology 132:104-106.
4. Arnone M, Millet L, Desclaux MF, Delgorge C, Keane P, Maffrand JP and Soubrié P SR141716 reduces weight gain in obese Zucker rats by regulating hyperphagia and activating fatty acid oxidation. Br J Pharmacol.
5. Baskin DG, Figlewicz LD, Seeley RJ, Woods SC, Porte D Jr, and Schwartz MW (1999) Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 848:114-123.
6. Berg AH, Combs TP, Du X, Brownlee M, and Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953.
7. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandras B, Pecceu F, Lupker J, et al. (1997) A selective inverse-agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin and insulin-like growth factor 1. J Biol Chem 272:22330-22339.
8. Campfield LA, Smith FJ, Mackie G, Tenenbaum R, Sassano ML, Mullin J, Kaiser K, and Kierstead RW (1995) Insulin normalization as an approach to the pharmacological treatment of obesity. Obes Res 3(Suppl 4):591s-603s.
9. Carpino PA (2000) Patent focus on new anti-obesity agents: September 1999-February 2000. Expert Opin Ther Patents 10:819-831.
10. Chaperon F, Soubrie P, Puech AJ, and Thiebot MH (1998) Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135:324-332.
11. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, and Gessa GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63:L113-L117.
12. Combs TP, Berg AH, Obici S, Scherer PE, and Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Investig 108:1875-1881.
13. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (Lond) 410:822-825.
14. Dugail I, Quignard-Boulange A, Le Liepvre X, Ardouin B, and Lavau M. (1992) Gene expression of lipid storage-related enzymes in adipose tissue of the genetically obese Zucker rat. Coordinated increase in transcriptional activity and potentiation by hyperinsulinaemia. Biochem J 281:607-611.
15. Elmquist JK, Elias CF, and Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221-232.
16. Fried SK and Russell C (1998) Diverse roles of adipose tissue in the regulation of systematic metabolism and energy balance, in Handbook of Obesity (Bray GA, Bouchard C, James W eds) pp 397-413, Marcel Dekker, New York.
17. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, and Lodish HF (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010.
18. Green H and Kehinde O (1973) Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113-116.
19. Halford JC and Blundell JE (2000) Pharmacology ofappetite suppression. Prog Drug Res 54:25-58.
20. Hu E, Liang P, and Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703.
21. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, and Kalra PS (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev 20:68-100.
22. Kuri-Harcuch W and Green H (1977) Increasing activity of enzymes on pathway of triacylglycerol synthesis during adipose conversion of 3T3 cells. J Biol Chem 252:2158-2160.
23. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, and Matsubara K (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289.
24. Must A, Spadano J, Coakley EH, Field AE, Colditz G, and Dietz WH (1999) The disease burden associated with overweight and obesity. J Am Med Assoc 282:1523-1529.
25. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, and Tomita M (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120:803-812.
26. Polonsky KS (2000) Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord 24 Suppl 2:S29-S31.
27. Proietto J, Fam BC, Ainslie DA, and Thorburn AW (2000) Novel anti-obesity drugs. Expert Opinion on Investigational Drugs 9:1317-1326.
28. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
29. Robbe D, Kopf M, Remaury A, Bockaert J, and Manzoni OJ (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99:8384-8388.
30. Scherer PE, Williams S, Fogliano M, Baldini G, and Lodish HF (1995) A novel serum protein similar to Clq, produced exclusively in adipocytes. J Biol Chem 270:26746-26749.
31. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, and Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935.
32. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, and Liu XH (2001) The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 74:683-701.
33. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946.